NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
![NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?](https://www.ohe.org/wp-content/uploads/2023/09/andrew-butler-aUu8tZFNgfM-unsplash-scaled.jpg)
OHE presented at the Global AMR R&D Hub Board of Members Meeting in Paris, on adapting HTA and payment mechanisms to incentivise new drugs to tackle AMR. This presentation was based on research by OHE, funded by the Wellcome Trust.
On 31st October 2019, Adrian Towse and Chris Henshall presented at the Global AMR R&D Hub Board Meeting in Paris.
The topic of their presentation was HTA and payment mechanisms for new drugs to tackle antimicrobial resistance. Specifically, after introducing the challenges of applying standard health technology assessment (HTA) and contracting methods to antibiotics, they discussed a number of proposals that have emerged in the academic literature and made pragmatic recommendations to progress the practical adoption of these potential solutions. The slides from their presentation can be viewed below.
This presentation draws on research by OHE, funded by the Wellcome Trust, on innovative HTA methods and contracting for antibiotics. A short four-page summary of the research was circulated at the meeting and is available to download as a PDF. Among the main findings of this work are that:
The full report of the study is available here.
Related research
Neri, M., Hampson, G., Henshall, C. and Towse, A., 2019. HTA and payment mechanisms for new drugs to tackle AMR. OHE Research Paper, London: Office of Health Economics. RePEc.
Ferraro, J., Towse, A. and Mestre-Ferrandiz, J., 2017. Incentives for New Drugs to Tackle Anti-Microbial Resistance. OHE Briefing. London: Office of Health Economics. RePEc.
Karlsberg Schaffer, S., West, P., Towse, A., Henshall, C., Mestre-Ferrandiz, J., Masterson, R. and Fischer, A., 2017. Assessing the Value of New Antibiotics: Additional Elements of Value for Health Technology Assessment Decisions. OHE Briefing. London: Office of Health Economics. RePEc.
An error has occurred, please try again later.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!